These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19625882)

  • 21. Major depressive disorder with psychotic features induced by interferon-alpha treatment for hepatitis C in a polydrug abuser.
    Kalyoncu OA; Tan D; Mirsal H; Pektas O; Beyazyurek M
    J Psychopharmacol; 2005 Jan; 19(1):102-5. PubMed ID: 15671136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Reflections on the treatment of EDM in hepatitis C virus patients treated with interferon alpha from a retrospective survey concerning 29 patients].
    Lang JP; Halleguen O; Vecchionacci V; Doffoel M
    Encephale; 2003; 29(3 Pt 1):273-7. PubMed ID: 12876553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychiatric symptoms related to interferon therapy for chronic hepatitis C: clinical features and prognosis.
    Hosoda S; Takimura H; Shibayama M; Kanamura H; Ikeda K; Kumada H
    Psychiatry Clin Neurosci; 2000 Oct; 54(5):565-72. PubMed ID: 11043807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness and tolerability of combination treatment of chronic hepatitis C in illicit drug users: meta-analysis of prospective studies.
    Zanini B; Covolo L; Donato F; Lanzini A
    Clin Ther; 2010 Dec; 32(13):2139-59. PubMed ID: 21316533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hepatitis C, interferon a and depression: main physiopathologic hypothesis].
    Vignau J; Karila L; Costisella O; Canva V
    Encephale; 2005; 31(3):349-57. PubMed ID: 16142050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychiatric and substance use disorders in individuals with hepatitis C: epidemiology and management.
    Loftis JM; Matthews AM; Hauser P
    Drugs; 2006; 66(2):155-74. PubMed ID: 16451091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel program for treating patients with trimorbidity: hepatitis C, serious mental illness, and active substance use.
    Sockalingam S; Blank D; Banga CA; Mason K; Dodd Z; Powis J
    Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1377-84. PubMed ID: 23680911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obstacles to successful HCV treatment in substance addicted patients.
    Cooper CL
    J Addict Dis; 2008; 27(2):61-8. PubMed ID: 18681192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon alfa-induced adverse effects in patients with a psychiatric diagnosis.
    Pariante CM; Landau S; Carpiniello B;
    N Engl J Med; 2002 Jul; 347(2):148-9. PubMed ID: 12110753
    [No Abstract]   [Full Text] [Related]  

  • 30. When do psychiatric side effects emerge during antiviral treatment of hepatitis C?
    Gazdag G; Horváth G; Szabó O; Takács R; Ungvari GS
    Psychiatr Danub; 2013 Dec; 25(4):398-400. PubMed ID: 24247052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between apolipoprotein E epsilon4 and neuropsychiatric symptoms during interferon alpha treatment for chronic hepatitis C.
    Gochee PA; Powell EE; Purdie DM; Pandeya N; Kelemen L; Shorthouse C; Jonsson JR; Kelly B
    Psychosomatics; 2004; 45(1):49-57. PubMed ID: 14709760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of mental health problems prior to and during treatment of hepatitis C virus infection in patients with drug addiction.
    Schaefer M; Sarkar R; Diez-Quevedo C
    Clin Infect Dis; 2013 Aug; 57 Suppl 2():S111-7. PubMed ID: 23884058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C treatment for people with severe mental illness.
    Mistler LA; Brunette MF; Marsh BJ; Vidaver RM; Luckoor R; Rosenberg SD
    Psychosomatics; 2006; 47(2):93-107. PubMed ID: 16508020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impulsiveness in chronic hepatitis C patients.
    Fábregas BC; Abreu MN; Dos Santos AK; Moura AS; Carmo RA; Teixeira AL
    Gen Hosp Psychiatry; 2014; 36(3):261-5. PubMed ID: 24456821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How persons with chronic hepatitis C in residential substance abuse treatment programs think about depression and interferon therapy.
    Rosedale MT; Strauss SM
    J Am Psychiatr Nurses Assoc; 2010 Nov; 16(6):350-6. PubMed ID: 21659284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A French prospective observational study of the treatment of chronic hepatitis C in drug abusers: a commentary].
    Michel L; Roux P; Cohen J; Carrieri MP
    Gastroenterol Clin Biol; 2009 Jan; 33(1 Pt 1):15-6; author reply 16-7. PubMed ID: 19084361
    [No Abstract]   [Full Text] [Related]  

  • 37. Hepatitis C and depression.
    Yates WR; Gleason O
    Depress Anxiety; 1998; 7(4):188-93. PubMed ID: 9706456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C treatment of veterans with psychiatric illness.
    Rifai MA; Loftis JM; Hauser P
    Am J Gastroenterol; 2006 Mar; 101(3):673-4; author reply 674-5. PubMed ID: 16542298
    [No Abstract]   [Full Text] [Related]  

  • 39. Hepatitis C, interferon alpha and psychiatric co-morbidity in intravenous drug users (IVDU) : guidelines for clinical practice.
    De Bie J; Robaeys G; Buntinx F
    Acta Gastroenterol Belg; 2005; 68(1):68-80. PubMed ID: 15832590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview.
    Adinolfi LE; Nevola R; Lus G; Restivo L; Guerrera B; Romano C; Zampino R; Rinaldi L; Sellitto A; Giordano M; Marrone A
    World J Gastroenterol; 2015 Feb; 21(8):2269-80. PubMed ID: 25741133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.